Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124501 | SCV000167934 | benign | not specified | 2013-02-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000124501 | SCV000303978 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Center for Human Genetics, |
RCV000659473 | SCV000781288 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001802946 | SCV002049724 | benign | Ehlers-Danlos syndrome, classic type, 2 | 2023-10-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002055500 | SCV002466348 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000124501 | SCV004803804 | benign | not specified | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000124501 | SCV001809032 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701607 | SCV001930637 | likely benign | not provided | no assertion criteria provided | clinical testing |